Form D · Other
Fuzzy Pet Health, Inc.
San Francisco, CA · CIK 0001724766
Offering snapshot reported Apr 13, 2022 · SEC filing
- Reported sold
- $18M Offering amount: $18M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2022 | Initial | $17,999,999 | No comparison | 11 | SEC filing |
| Apr 13, 2022 | Initial | $44,004,990 | No comparison | 17 | SEC filing |
| Dec 18, 2017 | Initial | $4,112,710 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-441654
(i) Series B Preferred Stock and (ii) Common Stock issuable upon conversion of Series B Preferred Stock.
Source: Form D, filed Apr 13, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zubin Bhettay | Director, Executive |
| Lawrence Coburn | Director |
| Anna Lena Kamenetzky | Director |
| Thomas Mawhinney | Director |
| Nihal Mehta | Director |
| Eric Palm | Director, Executive |
| Ian Sigalow | Director |
| Dana Stalder | Director |
Issuer details
Industry: Other (See others in industry)
Address:
160 Spear Street, Suite 1000
San Francisco, CA, 94105
San Francisco, CA, 94105